Fistula formation after postoperative radiation treatment for paranasal sinus cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 31, Issue 2, 2008, Pages 199-204

  Terezakis, Stephanie A ^a   Bohle III, George C ^a   Lee, Nancy Y ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Fistula; Paranasal sinus cancer; Radiation toxicity in head and neck cancer; Side effects of sinus cancer treatment

Indexed keywords

CANCER DIAGNOSIS; CANCER RADIOTHERAPY; FISTULA; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PARANASAL SINUS CANCER; PATIENT CARE; POSTOPERATIVE PERIOD; RADIATION DOSE; RADIATION INJURY; REVIEW;

CUTANEOUS FISTULA; FISTULA; HUMANS; ORAL FISTULA; OROANTRAL FISTULA; PARANASAL SINUS DISEASES; PARANASAL SINUS NEOPLASMS; PROSTHESES AND IMPLANTS; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 42049099331     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31815aff43     Document Type: Review

References (31)

1. Shah JP, Kraus DH, Bilsky MH, et al. Craniofacial resection for malignant tumors involving anterior skull base. Arch Otolaryngol Head Neck Surg. 1997;123:1312-1317.
2. Roa WH, Hazuka MB, Sandler HM, et al. Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinuses. Int J Radiat Oncol Biol Phys. 1994;28:857-865.
3. Daly ME, Chen AM, Bucci MK, et al. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys. 2007;67:151-157.
4. Hoppe BS, Stegman LD, Zelefsky MJ, et al. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting - the MSKCC experience. Int J Radiat Oncol Biol Phys. 2007;67:691-702.
5. Padovani L, Pommier P, Clippe S, et al. Three-dimensional conformal radiotherapy for paranasal sinus carcinoma: Clinical results for 25 patients. Int J Radiat Oncol Biol Phys. 2003;56:169-176.
6. Duthoy W, Boterberg T, Claus F, et al. Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patients. Cancer. 2005;104:71-82.
7. Harari PM, Huang SM. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. Int J Radiat Oncol Biol Phys. 2001;49:427-433.
8. Milas L, Mason K, Hunter N, et al. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin Cancer Res. 2000;6:701-708.
9. Huang SM, Bock JM, Harari PM. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res 1999;59:1935-1940.
10. Huang S, Harari PM. Modulation of radiation response following EGFR blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics and tumor angiogenesis. Clin Cancer Res. 2000;6:2166-2174.
11. Bonner JA, Harari P, Giralt J, et al. Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck. N Engl J Med. 2006;354:567-578.
12. Robert F, Ezekiel MP, Spencer SA. Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol. 2001;19:3234-3243.
13. Pfister DG, Su YB, Kraus DH, et al. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol. 2006;24:1072-1078.
14. Shukovsky L, Fletcher G. Retinal and optic nerve complications in a high dose irradiation technique of ethmoid sinus and nasal cavity. Radiology. 1972;104:629-634.
15. Ellingwood K, Million R. Cancer of the nasal cavity and ethmoid/sphenoid sinuses. Cancer. 1979;43:1517-1526.
16. Katz T, Mendenhall W, Morris C, et al. Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck. 2002;24:821-829.
17. Jiang G, Morrison W, Garden A, et al. Ethmoid sinus carcinomas: natural history and treatment results. Radiother Oncol. 1998;49:21-27.
18. Waldron J, O'Sullivan B, Warde P, et al. Ethmoid sinus cancer: twenty-nine cases managed with primary radiation therapy. Int J Radiat Oncol Biol Phys. 1998;41:361-369.
19. Karim A, Kralendonk J, Njo K, et al. Ethmoid and upper nasal cavity carcinoma: treatment, results, and complications. Radiother Oncol. 1990;19:109-120.
20. Adams EJ, Nutting CM, Convery DJ, et al. Potential role of intensity-modulated radiotherapy in the treatment of tumors of the maxillary sinus. Int J Radiat Oncol Biol Phys. 2003;55:776-784.
21. Huang D, Xia P, Akazawa P, et al. Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys. 2003;56:158-168.
22. Pacholke HD, Amdur RJ, Louis DA, et al. The role of intensity modulated radiation therapy for favorable stage tumor of the nasal cavity or ethmoid sinus. American Journal of Clinical Oncology. 2005;28:474-478.
23. Bristol IJ, Ahamad A, Garden AS, et al. Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment. Int J Radiat Oncol Biol Phys. 2007;68:719-730.
24. Luce EA. The irradiated wound. Surg Clin North Am. 1984;64:821-829.
25. Bernstein EF, Sullivan FJ, Mitchell JB, et al. Biology of chronic radiation effect on tissues and wound healing. Clin Plast Surg. 1993;20:435-453.
26. Drake DB, Oishi SN. Wound healing considerations in chemotherapy and radiation therapy. Clin Plast Surg. 1995;22:31-37.
27. Doyle JW, Li Y, Salloum A, et al. The effects of radiation on neovascularization in a rat model. Plast Reconstr Surg. 1996;98:129.
28. Tibbs MK. Wound healing following radiation therapy: a review. Radiother Oncol. 1997;42:99-106.
29. Springfield DS. Surgical wound healing. Cancer Treat Res. 1993;67:81-98.
30. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
31. Chang TL, Garrett N, Roumanas E, et al. Treatment satisfaction with facial prostheses. J Prosthet Dent. 2005;94:275-280.